Vectura welcomes the opportunity to work with partners and has a successful track record in doing so. We have assets and technology available for out-licensing, but also seek in-licensing opportunities and co-development arrangements.
We typically out license products aimed at large, primary-care markets; our current partners include major pharmaceutical firms.
We seek to in-license molecules for development through to clinical proof of concept, and typically seek a partner for later-stage development and commercialisation.
Vectura embraces co-development arrangements where the risks and rewards of product development are shared.
Vectura also out-licenses its proprietary device and formulation technologies to companies developing inhaled pharmaceuticals.
Licensing and collaboration